Get a job referral to Arrowhead Pharmaceuticals

Description

Arrowhead Pharmaceuticals (NASDAQ: ARWR) is a biopharmaceutical company that specializes in developing RNA interference (RNAi) therapeutics. Established in 1989, Arrowhead has been at the forefront of utilizing RNAi technology to address various diseases by silencing specific genes. The company's innovative approach has led to the development of a diverse pipeline of potential treatments for conditions such as liver and lung diseases, as well as various types of cancer. Arrowhead Pharmaceuticals continues to drive advancements in the field of RNAi therapeutics, offering promising solutions to unmet medical needs.